Conduit Pharmaceuticals Inc (NASDAQ: CDT) is -72.30% lower on its value in year-to-date trading and has touched a low of $1.75 and a high of $392.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CDT stock was last observed hovering at around $1.80 in the last trading session, with the day’s gains setting it 0.1%.
Currently trading at $1.90, the stock is -66.70% and -73.80% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.97 million and changing 5.56% at the moment leaves the stock -97.47% off its SMA200. CDT registered -99.32% loss for a year compared to 6-month loss of -89.45%. The firm has a 50-day simple moving average (SMA 50) of $7.4012 and a 200-day simple moving average (SMA200) of $76.6998.
The stock witnessed a -73.31% gain in the last 1 month and extending the period to 3 months gives it a -78.43%, and is -31.16% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.24% over the week and 25.70% over the month.
Conduit Pharmaceuticals Inc (CDT) has around 7 employees, a market worth around $2.92M and $0.00M in sales. Distance from 52-week low is 8.57% and -99.52% from its 52-week high.
52.0 institutions hold shares in Conduit Pharmaceuticals Inc (CDT), with institutional investors hold 7.97% of the company’s shares. The shares outstanding are 0.96M, and float is at 0.59M with Short Float at 7.81%. Institutions hold 4.06% of the Float.
Conduit Pharmaceuticals Inc (CDT) Insider Activity
The most recent transaction is an insider sale by Nirland Ltd, the company’s 10% Owner. SEC filings show that Nirland Ltd sold 1,500,000 shares of the company’s common stock on Oct 03 ’24 at a price of $0.10 per share for a total of $0.16 million. Following the sale, the insider now owns 8.4 million shares.
Conduit Pharmaceuticals Inc disclosed in a document filed with the SEC on Oct 04 ’24 that Nirland Ltd (10% Owner) sold a total of 1,368,991 shares of the company’s common stock. The trade occurred on Oct 04 ’24 and was made at $0.10 per share for $0.14 million. Following the transaction, the insider now directly holds 7.03 million shares of the CDT stock.
Still, SEC filings show that on Oct 07 ’24, Nirland Ltd (10% Owner) disposed off 939,009 shares at an average price of $0.10 for $96530.0. The insider now directly holds 6,092,000 shares of Conduit Pharmaceuticals Inc (CDT).
